Preeclampsia Test Helps Extend Pregnancy to Improve Outcomes

0:00 Welcome 0:34 Public policy insights for 2026: Dr. Bill Morice shares insights on reimbursement and AI-related policy developments following an association meeting in Washington, D.C. 4:45 An unprecedented year for test development: Discover how Mayo Clinic’s record year for test development delivers value to Mayo Clinic’s patients and Mayo Clinic Laboratories’ clients. 8:13 Novel preeclampsia testing: Learn how new clinical testing helps physicians improve outcomes for women at risk for preeclampsia and their babies. In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, to share industry updates and Mayo Clinic’s test development success in 2025. Later, Dr. Pritt welcomes Janelle Santos, M.D., a maternal-fetal medicine specialist at Mayo Clinic, to discuss how she uses a preeclampsia test to care for her patients. Note: Information in this post was accurate at the time of its posting.